First Ascent Biomedical
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
11740 SW 80th St Ste 102, Miami, Florida...Phone Number
(786) 746-6722Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About First Ascent Biomedical
First Ascent Biomedical offers personalized cancer treatment through their breakthrough drug prediction platform, DxPP. Their AI and therapy resistant cell technologies assist in treatment planning and drug development for cancer patients, providing highly individualized options for advanced cancer patients and a 10-day turnaround for oncologists. Additionally, their drug prediction platform accelerates the drug development pipeline for all types of cancer, with a focus on integrating functional drug testing, DNA/RNA sequencing, and AI-guided tumor mapping for tailored therapeutic solutions.Explore more
First Ascent Biomedical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is First Ascent Biomedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if First Ascent Biomedical had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at First Ascent Biomedical
Check if First Ascent Biomedical has recently received funding, and reach out quickly before it becomes old news!
Check out if First Ascent Biomedical is spiking on competitors!
First Ascent Biomedical, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on First Ascent Biomedical recently announced quarterly report
Product Launch: Get notified when First Ascent Biomedical launches new products
Funding: Get notified immidiatlly once First Ascent Biomedical has new funding data
Recommended Actions
Reach out to Masked Content who joined First Ascent Biomedical as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
First Ascent Biomedical is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
First Ascent Biomedical is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about First Ascent Biomedical.
First Ascent Biomedical financials insights
Gather financial insights about First Ascent Biomedical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$6M
Grant
$2M
First Ascent Biomedical Tech Stack
A closer look at the technologies used by First Ascent Biomedical
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Person-Based
Person-Based
Person-Based
First Ascent Biomedical News & Media
First Ascent Biomedical Opens FPM Cancer Lab in Miami; Welcomes World-Class Clinical Leadership
Miami lab is now accepting patient and physician referrals. Eligible Florida residents and colorectal cancer patients nationwide may qualify for limited sponsored programs covering the cost of testing. MIAMI, Feb. 16, 2026 /PRNewswire/ -- First Ascent Biomedical has announced the official...Behind the Relapse No One Saw Coming: How First Ascent Biomedical Is Changing Cancer Treatment Decisions
Logan Jenner, a five-year-old battling acute myeloid leukemia, found new hope through a clinical trial that used Functional Precision Medicine to guide a personalized treatment approach after standard therapies failed. MIAMI, Jan. 6, 2026 /PRNewswire/ -- In a groundbreaking development,...Disruption in Cancer Care: How Jim Foote' AI is Revolutionizing Oncology
Jim Foote, CEO of First Ascent Biomedical, is revolutionizing cancer care with an AI-driven, functional precision medicine platform. Inspired by his son's battle, Foote's technology analyzes a patient's tumor to identify the most effective treatments, moving from a "one-size-fits-all"...First Ascent Biomedical Reports 83% Patient Benefit Rate Using Functional Precision Medicine Platform
First Ascent Biomedical is transforming cancer care with a novel platform that combines patient-derived testing, genomic profiling, and AI to deliver personalized treatment decisions. Its Sept. 1 lab opening will ramp up testing, which early research, published in Nature Medicine, shows...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding First Ascent Biomedical
Sign Up For FreeTo access detailed company insights
First Ascent Biomedical offers personalized cancer treatment through their breakthrough drug prediction platform, DxPP. Their AI and therapy resistant cell technologies assist in treatment planning and drug development for cancer patients, providing highly individualized options for advanced cancer patients and a 10-day turnaround for oncologists.... Read More
